CardioBiomed

Unique AI based cardiovascular medical device raising funds for prototype development.

Facebook Twitter LinkedIn

AI enabled cardiovascular medical device addressing the unmet need to reduce acute kidney injury caused by contrast dye usage during interventional procedures.
Contrast Induced Acute Kidney injury (CI-AKI) costs Hospitals millions of dollars a year and puts already compromised patients at risk of kidney failure and other severe complications.
CardiooBiomed has a unique AI based device that will automatically reduce the risk of CI-AKI, saving hospital and health care systems millions of dollars while protecting patients.

Ready to Ask For Funding for your company?

Post a Funding Request

CardioBiomed is no longer seeking funding.